Imeglimin population pharmacokinetics and dose adjustment predictions for renal impairment in Japanese and Western patients with type 2 diabetes

Por Yoshiko Tomita, Emma Hansson, Florent Mazuir, Gustaf J Wellhagen, Qing Xi Ooi, Enrica Mezzalana, Atsushi Kitamura, Daisuke Nemoto, Sébastien Bolze
Publicado em 2022-04-01